Choi, E.; Ramirez Tovar, A.; He, Z.; Soler Rodriguez, D.M.; Vos, M.B.; Arora, S.; Fadoju, D.
Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD). Children 2024, 11, 275.
https://doi.org/10.3390/children11030275
AMA Style
Choi E, Ramirez Tovar A, He Z, Soler Rodriguez DM, Vos MB, Arora S, Fadoju D.
Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD). Children. 2024; 11(3):275.
https://doi.org/10.3390/children11030275
Chicago/Turabian Style
Choi, Erika, Ana Ramirez Tovar, Zhulin He, Dellys M. Soler Rodriguez, Miriam B. Vos, Shruthi Arora, and Doris Fadoju.
2024. "Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)" Children 11, no. 3: 275.
https://doi.org/10.3390/children11030275
APA Style
Choi, E., Ramirez Tovar, A., He, Z., Soler Rodriguez, D. M., Vos, M. B., Arora, S., & Fadoju, D.
(2024). Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD). Children, 11(3), 275.
https://doi.org/10.3390/children11030275
